HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection

Journal of General Virology

Volumn 89, Issue 12, 2008, Pages 3034-3038

  Bonvicini, Francesca ^a   Filippone, Claudia ^a,b   Manaresi, Elisabetta ^a   Zerbini, Marialuisa ^a   Musiani, Monica ^a   Gallinella, Giorgio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ANTIGEN ANTIBODY REACTION; APLASTIC ANEMIA; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL STRAIN HEPG2; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHEMA INFECTIOSUM; GENE REPLICATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOFLUORESCENCE TEST; LIVER CELL CARCINOMA; NONHUMAN; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS HEPATITIS; VIRUS INFECTIVITY; BIOSYNTHESIS; CYTOLOGY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIVER CELL; METHODOLOGY; PATHOGENICITY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

PARVOVIRUS;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, VIRAL; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTES; HUMANS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL PROTEINS; VIROLOGY; VIRUS REPLICATION;

EID: 58149393404     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/004341-0     Document Type: Article

References (20)

1. Abe, K., Kiuchi, T., Tanaka, K., Edamoto, Y., Aiba, N. & Sata, T. (2007). Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation. Int J Med Sci 4, 105-109.
2. Bonvicini, F., Filippone, C., Delbarba, S., Manaresi, E., Zerbini, M., Musiani, M. & Gallinella, G. (2006). Parvovirus B19 genome as a single, two-state replicative and transcriptional unit. Virology 347, 447-454.
3. Brown, K. E., Anderson, S. M. & Young, N. S. (1993). Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114-117.
4. Caillet-Fauquet, P., Di Giambattista, M., Draps, M. L., Hougardy, V., de Launoit, Y. & Laub, R. (2004). An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines. Transfusion 44, 1340-1343.
5. Eis-Hubinger, A. M., Reber, U., Abdul-Nour, T., Glatzel, U., Lauschke, H. & Putz, U. (2001). Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65, 395-401.
6. Gallinella, G., Bonvicini, F., Filippone, C., Delbarba, S., Manaresi, E., Zerbini, M. & Musiani, M. (2004). Calibrated real-time PCR for evaluation of parvovirus B19 viral load. Clin Chem 50, 759-762.
7. Hillingso, J. G., Jensen, I. P. & Tom-Petersen, L. (1998). Parvovirus B19 and acute hepatitis in adults. Lancet 351, 955-956.
8. Karetnyi, Y. V., Beck, P. R., Markin, R. S., Langnas, A. N. & Naides, S. J. (1999). Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144, 1713-1724.
9. Langnas, A. N., Markin, R. S., Cattral, M. S. & Naides, S. J. (1995). Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22, 1661-1665.
10. Naides, S. J., Karetnyi, Y. V., Cooling, L. L., Mark, R. S. & Langnas, A. N. (1996). Human parvovirus B19 infection and hepatitis. Lancet 347, 1563-1564.
11. Pardi, D. S., Romero, Y., Mertz, L. E. & Douglas, D. D. (1998). Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 93, 468-470.
12. Pinho, J. R., Alves, V. A., Vieira, A. F., Moralez, M. O., Fonseca, L. E., Guz, B., Wakamatsu, A., Cancado, E. L., Carrilho, F. J. & other authors (2001). Detection of human parvovirus B19 in a patient with hepatitis. Braz J Med Biol Res 34, 1131-1138.
13. Poole, B. D., Karetnyi, Y. V. & Naides, S. J. (2004). Parvovirus B19-induced apoptosis of hepatocytes. J Virol 78, 7775-7783.
14. Poole, B. D., Zhou, J., Grote, A., Schiffenbauer, A. & Naides, S. J. (2006). Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol 80, 4114-4121.
15. Sokal, E. M., Melchior, M., Cornu, C., Vandenbroucke, A. T., Buts, J. P., Cohen, B. J. & Burtonboy, G. (1998). Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352, 1739-1741.
16. Tsuda, H. (1993). Liver dysfunction caused by parvovirus B19. Am J Gastroenterol 88, 1463.
17. Weigel-Kelley, K. A., Yoder, M. C. & Srivastava, A. (2003). α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry. Blood 102, 3927-3933.
18. Wong, S., Young, N. S. & Brown, K. E. (2003). Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187, 1581-1586.
19. Yoto, Y., Kudoh, T., Haseyama, K., Suzuki, N. & Chiba, S. (1996). Human parvovirus B19 infection associated with acute hepatitis. Lancet 347, 868-869.
20. Young, N. S. & Brown, K. E. (2004). Parvovirus B19. N Engl J Med 350, 586-597.